IMGN ImmunoGen Inc
Market Cap
1.02B
Day’s Range
52W Range
Volume (3M)
3.6M
Price-Earnings Ratio
-
Revenue
95.61M
ImmunoGen Inc Latest News
Top Discussions
24
FEB
REPORTS
ImmunoGen Inc Q4 2022 earnings report is expected to be released before market open

IMGN
ImmunoGen Inc
4.73
0.10
(2.22%)

IMGN
ImmunoGen Inc
4.73
0.10 (2.22%)
About ImmunoGen Inc
Operating internationally, ImmunoGen is a clinical-stage biotechnology company. The company develops cancer treatments using antibody-based therapies. With headquarters based in Waltham, Massachusetts, the company was founded in 1980. ImmunoGen stock is available on the NASDAQ GS stock market under the IMGN ticker. Make IMGN stock an entry on your eToro watchlist to keep up with its price movements.
Show More106
Employees
Waltham, Massachusetts, US
HQ
1981
Founded
Mark Joseph Enyedy
CEO
Upcoming Earnings
24
FEB
REPORTS
ImmunoGen Inc Q4 2022 earnings report is expected to be released before market open
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
41
Very Low
Industry
Avg. 45
32
Environment
45
Social
42
Governance